An increasing number of reports describing the use of DNA probes for the clinical diagnosis of specific pathogens are now appearing in the scientific literature. So far as antibiotic resistance is concerned, DNA probes have been used primarily to obtain information regarding the dissemination of particular antibiotic resistance genes and to obtain information regarding their evolutionary relationships (e.g. Towner et al., 1991) . However, since primary isolation and growth of an infecting organism is not necessarily required for a successful hybridization test, one of the major potential advantages of DNA probes is that they could be used directly to detect antimicrobial resistance of bacteria present in patient specimens, with obvious concomitant clinical advantages. Such probe-based tests would permit the rapid screening of large numbers of samples, with possibilities for automation; the feasibility of this approach has already been demonstrated with infected urine specimens (Carter et al., 1989) . Now that non-radioactive methods of probe-labelling are available commercially, it is particularly clear that DNA probes at least merit further investigation as an alternative test for presence of antimicrobial resistance in bacteria.
A major consideration is the type of resistance that can be detected by DNA probes. Resistance resulting from the presence of specific genes, often encoding particular enzymes such as plasmid-mediated /J-lactamases, aminoglycoside-inactivating enzymes or dihydrofolate redudases, is readily amenable to detection by DNA probes. In contrast, resistance resulting from random spontaneous mutation of genes on the bacterial chromosome cannot be detected so easily. Although such mutations, which often involve changes in only a single base pair of DNA, can theoretically be detected by means of specific oligonucleotide probes, in practice it would be impossible to produce probes capable of detecting all possible spontaneous mutations. Thus DNA probe analysis of antimicrobial resistance for diagnostic purposes is effectively limited to the detection of resistance associated with identifiable structural genes.
A second consideration concerns the meaning of the term 'resistance'. Microbiologists and clinicians have become accustomed to the idea that an organism is 'resistant' when it is inhibited in vitro by an antibiotic concentration which is greater than that achievable in vivo. In contrast with this somewhat limited traditional definition, a positive DNA hybridization result provides direct evidence that an organism has the potential for resistance, in that it carries a particular resistance gene. It does not mean that such a resistance gene is necessarily being expressed. Little is known about the frequency with which cryptic resistance genes occur in clinical isolates of bacteria, and even less about the possibility that they can become 'switched-on' during the selection pressures that occur during therapy, which might cause treatment to fail in an organism considered to be 'sensitive' by conventional criteria. From a clinical viewpoint, the occasional false-positive resistance result obtained by detection of a cryptic resistance gene with a DNA probe might not be too serious, since the patient would, presumably, be treated with an alternative antibiotic.
The ability to detect specific resistance genes depends on the availability of the corresponding DNA probes. Much clinically-relevant antibiotic resistance is encoded by genes carried on plasmids. By 1988, a significant number of probes had already been developed for the major resistance classes, particularly those found in Gram-negative bacteria (Halbert, 1988) . Many additional examples of such probes can be found in the more recent literature. In most cases, these probes have been constructed by cloning part of the gene conferring resistance, usually following detailed characterization of the original plasmid. They are often relatively large in size (up to several kb) and may not always be efficient at distinguishing between closelyrelated resistance genes in the same family (Amyes & Towner, 1990; Towner, 1990) . In such cases it may be necessary to synthesize small oligonucleotide probes that are capable of recognizing differences in single base pairs (Mabilat & Courvalin, 1990) . Such probes are ideal for epidemiological studies in that, normally, they are completely specific for a particular resistance gene. However, for diagnostic work it is necessary to detect all genes conferring resistance to a particular antibiotic. One possibility would be to use a 'cocktail' of aerkk probes that recognizes all genes conferring resistance to a particular antibiotic; alternatively, a DNA sequence present in all resistance genes of a particular class could be used as a 'universal probe', as has been proposed for /7-lactam resistance (Boissinot, Mercia & Levesque, 1987). In any event, probe construction and labelling is not a task for a diagnostic laboratory; it will be necessary for DNA probes to be made available in kit form before hybridization tests of antibiotic resistance can be considered for routine use.
Since the major diagnostic advantage of using a DNA probe is the time saved by not having to isolate or grow an infecting organism, a further consideration concerns the type of specimen that might be screened directly. Ideally the specimen should not contain too much debris and should be free from commensal flora which may possess the same antibiotic resistance genes as those found in a target pathogen. Specimens from normally sterile body sites will therefore give the best results. Such specimens might include blood, CSF, pleura] fluid and urine, although this preference should be balanced against the fact that reasonable numbers of a pathogenic organism will be required for direct detection to be successful. Not all types of specimens will be suitable for DNA probe analysis. Most methods described in the literature for 'routine' DNA probe-based assays tend to be an extrapolation of methods used in research laboratories where much still remains to be discovered about the possible ideal conditions for routine diagnostic use.
Conventional antimicrobial susceptibility testing is an assessment of phenotypic behaviour which, while not an exact science, represents an acceptable estimate of an organism's response to a particular antibiotic (Jones, 1983). As discussed by Tenovcr (1989), DNA probes offer a different way of looking at resistance, in that they examine the genetic potential of an organism to exhibit resistance. This is certainly different, but may not be less effective. Problems such as tolerance or inoculum effects, which often make disc and MIC tests difficult to interpret, are no longer relevant since it is the simple presence or absence of potential resistance genes which is detected. Of course, other problems emerge in their place, and it is difficult to imagine the complete replacement of disc diffusion and MIC tests in the foreseeable future. However, commercially-available hybridization tests for detecting the presence of specific pathogens, as opposed to antibiotic resistance, are already gaining acceptance in some diagnostic laboratories, particularly in the USA. In comparison, DNA probe-based tests for antimicrobial resistance are still in their infancy and further developments can be expected. The eventual availability of such tests for possible routine use will first require further information on the epidemiological distribution of resistance genes in different bacterial genera, details of the frequency at which resistance genes are carried by bacteria but not expressed, and knowledge of the frequency with which such resistance genes can become 'switched-on' during antimicrobial therapy.
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